News

Deal Announcements

Alafair Biosciences Secures New Funding

Thursday, October 29, 2015 5:40:00 AM PDT | VentureDeal
   Austin, Texas  --  Medical technology company Alafair Biosciences has landed $984,000 in new equity investment, according to an SEC filing.

Alafair is commercializing a hydrogel platform technology from the University of Texas that it has acquired the a worldwide exclusive rights to.

Investors in the financing were not disclosed, nor was how the company plans to use the funding proceeds.

Alafair is still seeking $1 million in additional equity investment, according to the filing.

Neurosurgeon Daniel Peterson is company CEO.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1